Cantel Medical (CMD) has a profit margin of 4.57%, below the Healthcare sector average of 9.48%.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2021
Trailing 12 months ending Apr 2021
Cantel Medical posts a profit margin of 4.57% as of April 2021. That compares with 2.75% in the prior-year period — up 66.3% year over year. That is below the Healthcare sector average of 9.48%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Cantel Medical's profit margin was 2.75%. The latest reading is 4.57% — a 66.3% year-over-year increase (period ending April 2021). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a profit margin near 9.48% is typical. Cantel Medical's 4.57% is lower that level. That is roughly 51.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Cantel Medical's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 4.57% as of April 2021; use YoY and peer views to separate noise from signal.
Context for CMD's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.48%), and (3) consistency with growth and profitability. This page covers the first two; Cantel Medical's other metric pages and overview cover the third.